New‐onset vitiligo following mRNA‐1273 (Moderna) COVID‐19 vaccination
Abstract The COVID‐19 mRNA vaccines not only provide remarkable protection but also have been characterized by an overall safe and well‐tolerated side effect profile. Herein, we discuss a rare but manageable cutaneous reaction to COVID vaccination in order to further characterize dermatologic reacti...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-09-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.4865 |
| _version_ | 1818438081012826112 |
|---|---|
| author | Joshua Kaminetsky Donald Rudikoff |
| author_facet | Joshua Kaminetsky Donald Rudikoff |
| author_sort | Joshua Kaminetsky |
| collection | DOAJ |
| description | Abstract The COVID‐19 mRNA vaccines not only provide remarkable protection but also have been characterized by an overall safe and well‐tolerated side effect profile. Herein, we discuss a rare but manageable cutaneous reaction to COVID vaccination in order to further characterize dermatologic reactions and stress the continued vaccination of eligible patients. |
| first_indexed | 2024-12-14T17:34:53Z |
| format | Article |
| id | doaj.art-73cdd13371d94ff3a2ec4c46e8c61b86 |
| institution | Directory Open Access Journal |
| issn | 2050-0904 |
| language | English |
| last_indexed | 2024-12-14T17:34:53Z |
| publishDate | 2021-09-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical Case Reports |
| spelling | doaj.art-73cdd13371d94ff3a2ec4c46e8c61b862022-12-21T22:53:01ZengWileyClinical Case Reports2050-09042021-09-0199n/an/a10.1002/ccr3.4865New‐onset vitiligo following mRNA‐1273 (Moderna) COVID‐19 vaccinationJoshua Kaminetsky0Donald Rudikoff1Department of Dermatology Icahn School of Medicine at Mount Sinai New York New York USADepartment of Dermatology BronxCare Health System Bronx New York USAAbstract The COVID‐19 mRNA vaccines not only provide remarkable protection but also have been characterized by an overall safe and well‐tolerated side effect profile. Herein, we discuss a rare but manageable cutaneous reaction to COVID vaccination in order to further characterize dermatologic reactions and stress the continued vaccination of eligible patients.https://doi.org/10.1002/ccr3.4865adverse reactionCOVID‐19mRNA vaccinevitiligo |
| spellingShingle | Joshua Kaminetsky Donald Rudikoff New‐onset vitiligo following mRNA‐1273 (Moderna) COVID‐19 vaccination Clinical Case Reports adverse reaction COVID‐19 mRNA vaccine vitiligo |
| title | New‐onset vitiligo following mRNA‐1273 (Moderna) COVID‐19 vaccination |
| title_full | New‐onset vitiligo following mRNA‐1273 (Moderna) COVID‐19 vaccination |
| title_fullStr | New‐onset vitiligo following mRNA‐1273 (Moderna) COVID‐19 vaccination |
| title_full_unstemmed | New‐onset vitiligo following mRNA‐1273 (Moderna) COVID‐19 vaccination |
| title_short | New‐onset vitiligo following mRNA‐1273 (Moderna) COVID‐19 vaccination |
| title_sort | new onset vitiligo following mrna 1273 moderna covid 19 vaccination |
| topic | adverse reaction COVID‐19 mRNA vaccine vitiligo |
| url | https://doi.org/10.1002/ccr3.4865 |
| work_keys_str_mv | AT joshuakaminetsky newonsetvitiligofollowingmrna1273modernacovid19vaccination AT donaldrudikoff newonsetvitiligofollowingmrna1273modernacovid19vaccination |